Complejo Asistencial Universitario de León-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2010

  1. BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)

    Annals of Hematology, Vol. 89, Núm. 5, pp. 453-458